InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: Whalatane post# 368146

Sunday, 01/30/2022 5:34:36 PM

Sunday, January 30, 2022 5:34:36 PM

Post# of 426480
There were 662 potential subjects in screening ...

... at time presentation was developed (likely early June). If 450 of these had moved to 'consented to study drug' between June 1st and June 18th, that would have taken the number to 1700, which may be getting close to "almost 2000", depending on the speaker. Median time to consent was 17 days, so it is possible there was a bunch of the 662 that got processed between June 1 and 18. Study recruitment very much dependent upon the efforts put forth by the staff. There could have been a push given the upcoming NIH presentation.


Re the 2,000 on IPE at time of presentation June 18th ...Good catch by poster IRYO But from memory they had 1254 enrolled in the IPE arm on June 1st ....to add another 746 in 18 days when they had averaged about 150 a month previously ?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News